XKDCT080
- Generic Name
- XKDCT080
XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation
Not Applicable
Recruiting
- Conditions
- Colon Cancer
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 9
- Registration Number
- NCT05875402
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath